MET - Metlife Stock

Market Summary

USD66.09-0.27

Market Closed

-0.41%

MET Alerts

Big fall in earnings (Y/Y)

MET Stock Price

MET RSI Chart

MET Valuation

Market Cap

50.0B

Price/Earnings (Trailing)

22.49

Price/Sales (Trailing)

0.71

EV/EBITDA

9.17

Price/Free Cashflow

4.23

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

3.45%

Return on Equity

6.06%

Return on Assets

0.29%

Free Cashflow Yield

23.65%

MET Fundamentals

MET Revenue

Revenue (TTM)

70.6B

Revenue Y/Y

7.43%

Revenue Q/Q

8.03%

MET Earnings

Earnings (TTM)

2.2B

Earnings Y/Y

-55.82%

Earnings Q/Q

372.94%

Price Action

52 Week Range

48.9577.36

(Low)(High)

Last 7 days

3.6%

Last 30 days

6.7%

Last 90 days

22.7%

Trailing 12 Months

1.6%

MET Financial Health

MET Investor Care

Dividend Yield

3.07%

Dividend/Share (TTM)

2.03

Buy Backs (1Y)

5.06%

Diluted EPS (TTM)

2.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for MET

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-09-14	Herzog David L	acquired	3,032	65.93	46.00	-
2023-09-14	GRISE CHERYL W	acquired	39,096	65.93	593	-
2023-09-14	KELLY EDWARD J III	acquired	16,086	65.93	244	-
2023-09-14	Johnson Jeh C.	acquired	923	65.93	14.00	-
2023-09-14	MCKENZIE DIANA	acquired	8,439	65.93	128	-
2023-09-14	HASSELL GERALD L	acquired	9,823	65.93	149	-
2023-09-14	Kinney Catherine R	acquired	18,658	65.93	283	-
2023-09-14	HUBBARD ROBERT GLENN	acquired	41,272	65.93	626	-
2023-09-14	Kennard William E	acquired	18,987	65.93	288	-
2023-08-31	TADROS RAMY	acquired	-	-	7,894	president, u.s. business

Which funds bought or sold MET recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-09-19	BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL	reduced	-17.19	-420,757	1,769,950	0.74%
2023-09-13	CGC Financial Services, LLC	new	-	6,444	6,444	-%
2023-09-12	Farther Finance Advisors, LLC	reduced	-9.98	-9,091	65,739	0.01%
2023-09-08	TUCKER ASSET MANAGEMENT LLC	unchanged	-	-826	33,127	0.01%
2023-09-07	ST GERMAIN D J CO INC	new	-	92,822	92,822	-%
2023-09-01	Portside Wealth Group, LLC	new	-	735,817	735,817	0.14%
2023-08-29	Garde Capital, Inc.	new	-	460,000	460,000	0.04%
2023-08-24	Alberta Investment Management Corp	unchanged	-	-58,374	2,340,340	0.02%
2023-08-23	Rehmann Capital Advisory Group	reduced	-4.6	-57,996	780,357	0.07%
2023-08-23	Stonebridge Capital Advisors LLC	added	26.09	7,887	42,323	-%

Latest Funds Activity

Are funds buying MET calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MET

No. of Funds

MET Alerts

Big fall in earnings (Y/Y)

Schedule 13G FIlings of Metlife

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Aug 04, 2023	board of directors of metlife inc	16.0%	120,043,226	SC 13D/A
May 04, 2023	board of directors of metlife inc	15.9%	121,521,424	SC 13D/A
Feb 23, 2023	board of directors of metlife inc	15.9%	122,923,807	SC 13D/A
Feb 14, 2023	dodge & cox	6.8%	53,583,210	SC 13G/A
Feb 09, 2023	vanguard group inc	7.08%	55,519,588	SC 13G/A
Jan 31, 2023	blackrock inc.	7.1%	55,514,415	SC 13G/A
May 05, 2022	board of directors of metlife inc	15.6%	127,128,424	SC 13D/A
Feb 14, 2022	dodge & cox	7.0%	58,725,183	SC 13G/A
Feb 09, 2022	vanguard group inc	6.77%	56,951,725	SC 13G/A
Feb 03, 2022	blackrock inc.	8.5%	71,686,373	SC 13G/A

Recent SEC filings of Metlife

View All Filings

Date Filed	Form Type	Document
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 18, 2023	4	Insider Trading
Sep 05, 2023	4	Insider Trading

Peers (Alternatives to Metlife)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MET	50.0B	70.6B	6.68%	1.60%	22.49	0.71	4.01%	-58.32%
PRU	38.7B	64.4B	8.46%	7.56%	125.56	0.61	4.97%	-6.22%
TRV	38.7B	38.7B	4.54%	6.04%	17.31	1	8.33%	-37.32%
RE	25.2B	13.3B	0.67%	24.34%	20.79	1.9	12.64%	55.58%
GL	11.7B	5.3B	-1.65%	6.99%	17.51	2.22	1.78%	-46.10%
ATH	-	22.8B	-	-	-	-	34.59%	179.04%
MID-CAP
PRI	7.2B	2.7B	-0.13%	55.74%	15.98	2.64	-1.39%	16.12%
LNC	4.4B	15.3B	0.50%	-43.85%	-3.31	0.29	-26.53%	-139.84%
AEL	4.2B	2.7B	2.00%	43.46%	3.53	1.58	38.34%	-32.53%
BHF	3.4B	1.9B	7.96%	5.39%	2.13	1.8	-77.15%	-71.29%
GNW	2.7B	7.5B	3.00%	49.36%	5.07	0.36	-1.40%	-38.58%
SMALL-CAP
VERY	81.1M	171.0M	-2.50%	-17.43%	-6.56	0.47	-0.92%	29.17%
AAME	39.9M	187.0M	2.62%	-36.73%	60.43	0.21	-4.23%	-77.34%

Metlife News

Returns for MET

Cumulative Returns on MET

7.8%

10-Year Cumulative Returns

10.9%

7-Year Cumulative Returns

9.6%

5-Year Cumulative Returns

21.5%

3-Year Cumulative Returns

Risks for MET

What is the probability of a big loss on MET?

49.2%

Probability that Metlife stock will be more than 20% underwater in next one year

27.3%

Probability that Metlife stock will be more than 30% underwater in next one year.

18.9%

Probability that Metlife stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MET drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Metlife was unfortunately bought at previous high price.

Drawdowns

Financials for Metlife

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)																					(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Revenue	1.7%	70,597	69,448	69,898	73,238	67,873	70,923	71,080	70,409	69,519	65,094	67,842	65,567	68,230	71,628	69,620	68,139	65,750	69,438	67,941	68,119	68,001
Operating Expenses	1.9%	12,121	11,896	12,034	11,854	12,415	12,388	12,586	12,739	12,925	13,027	13,150	13,357	13,330	13,737	13,689	13,453	13,479	13,574	13,714	14,071	13,920
EBITDA	-100.0%	-	3,339	3,764	3,337	4,970	9,461	9,040	7,902	6,770	2,483	7,818	7,314	9,166	11,338	7,451	-	-	-	-	-	-
EBITDA Margin	-100.0%	-	0.05*	0.05*	0.05*	0.07*	0.13*	0.13*	0.11*	0.10*	0.04*	0.12*	0.11*	0.13*	0.16*	0.11*	-	-	-	-	-	-
Interest Expenses	0.4%	942	938	905	899	909	911	914	918	905	908	891	896	880	952	964	968	1,048	1,035	1,130	1,121	1,205
Earnings Before Taxes	-16.5%	2,833	3,391	2,859	4,648	6,271	9,770	8,126	6,984	5,865	1,575	6,927	6,726	8,594	10,694	6,795	9,303	7,591	6,395	6,307	4,797	4,203
EBT Margin	-100.0%	-	0.03*	0.04*	0.03*	0.06*	0.12*	0.11*	0.10*	0.08*	0.02*	0.10*	0.10*	0.13*	0.15*	0.10*	-	-	-	-	-	-
Net Income	-18.6%	2,225	2,733	2,539	4,149	5,338	7,835	6,554	5,512	4,634	1,372	5,410	5,845	7,323	8,919	5,899	7,373	6,101	5,251	5,123	5,373	4,370
Net Income Margin	-100.0%	-	0.03*	0.04*	0.03*	0.05*	0.10*	0.09*	0.08*	0.07*	0.02*	0.08*	0.09*	0.11*	0.12*	0.08*	-	-	-	-	-	-
Free Cashflow	-100.0%	-	13,190	13,204	16,010	15,238	13,054	12,596	12,409	12,696	11,288	11,639	11,667	12,020	13,561	13,786	-	-	-	-	-	-

Balance Sheet
(In Millions)

Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Assets	0.4%	677,279	674,266	663,072	650,104	662,893	724,284	759,708	761,664	773,253	769,814	795,146	780,492	767,583	737,741	740,463	742,812	732,167	713,188	687,538	698,451	706,333
Cash Equivalents	-16.5%	15,417	18,456	20,195	22,200	20,548	23,488	20,047	18,956	25,037	19,635	19,795	24,405	24,289	24,094	16,598	19,452	18,435	14,506	15,821	12,490	16,312
Goodwill	-1.3%	9,261	9,379	9,297	9,005	9,151	9,510	9,535	9,638	9,768	9,944	10,112	9,360	9,245	9,159	9,308	9,278	9,408	9,418	9,422	9,440	9,499
Liabilities	0.8%	646,787	641,843	632,947	624,774	625,526	670,047	691,959	692,331	703,830	703,677	720,329	706,923	691,643	667,278	674,081	674,193	668,121	654,450	634,580	646,642	652,501
Short Term Borrowings	19.0%	200	168	175	183	196	323	341	346	393	302	393	351	303	298	235	142	158	289	268	290	479
Shareholder's Equity	-6.7%	30,261	32,423	29,881	25,076	34,009	42,703	50,013	69,333	69,423	66,137	74,817	73,569	75,940	70,463	66,382	68,619	64,046	58,738	52,958	51,809	53,832
Retained Earnings	-0.1%	39,928	39,957	40,332	41,032	41,101	41,406	41,197	40,426	39,318	36,373	31,824	36,782	36,568	36,919	33,078	32,948	31,209	29,944	28,926	27,331	26,870
Additional Paid-In Capital	0.0%	33,630	33,617	33,616	33,589	33,548	33,531	33,511	33,457	33,440	33,910	33,812	33,744	33,728	33,711	32,680	32,639	32,602	32,535	32,474	32,475	32,454
Shares Outstanding	-1.6%	757	769	779	787	798	815	826	845	861	878	893	906	908	908	915	920	936	950	959	987	1,000
Minority Interest	0.9%	231	229	244	254	266	272	267	283	285	273	259	253	247	242	238	251	235	229	217	184	199

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Last 12 Months)																					(In Millions)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Cashflow From Operations	-10.3%	11,835	13,190	13,204	16,010	15,279	13,140	12,596	12,409	12,696	11,288	11,639	11,667	12,020	13,561	13,786	9,906	9,293	12,514	11,738	12,487	13,688
Cashflow From Investing	-228.8%	-12,159	-3,698	-2,620	-5,285	-9,453	-10,559	-11,187	-10,487	-8,886	-11,286	-18,569	-23,500	-22,172	-20,224	-17,586	-5,135	-6,012	-10,848	-5,634	-10,710	-14,491
Cashflow From Financing	66.4%	-4,801	-14,268	-10,108	-6,742	-9,666	1,054	-1,375	-7,033	-3,040	-3,992	10,729	16,713	16,155	16,409	4,568	2,245	-1,163	-703	-2,801	-2,064	-100
Dividend Payments	-0.6%	1,581	1,590	1,598	1,610	1,623	1,636	1,647	1,657	1,663	1,661	1,657	1,648	1,642	1,642	1,643	1,652	1,658	1,667	1,678	1,685	1,693
Buy Backs	-14.0%	2,722	3,166	3,326	3,906	4,247	4,244	4,303	3,698	2,763	1,650	1,151	830	1,535	2,285	2,285	3,235	3,086	3,451	3,992	3,414	3,273

MET Income Statement

2023-06-30

Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Premiums	$ 11,678		$ 11,556		$ 21,267	$ 22,173
Universal life and investment-type product policy fees	1,288		1,372		2,577	2,684
Net investment income	5,072		3,583		9,717	7,867
Other revenues	621		615		1,260	1,275
Net investment gains (losses)	(1,039)		(682)		(1,723)	(1,199)
Net derivative gains (losses)	(997)		(970)		(1,087)	(1,921)
Total revenues	16,623		15,474		32,011	30,879
Expenses
Policyholder benefits and claims	11,809		11,615		21,681	22,789
Policyholder liability remeasurement (gains) losses	(16)		(1)		(25)	(42)
Market risk benefit remeasurement (gains) losses	(817)		(757)		(629)	(2,197)
Interest credited to policyholder account balances	1,933		527		3,797	1,153
Policyholder dividends	151		194		310	393
Other expenses	3,133		2,908		6,190	5,860
Total expenses	16,193		14,486		31,324	27,956
Income (loss) before provision for income tax	430		988		687	2,923
Provision for income tax expense (benefit)	22		73		194	369
Net income (loss)	408	$ 85	915	$ 1,639	493	2,554
Less: Net income (loss) attributable to noncontrolling interests	6		5		11	10
Net income (loss) attributable to MetLife, Inc.	402		910		482	2,544
Less: Preferred stock dividends	32	$ 66	29	$ 63	98	92
Net income (loss) available to MetLife, Inc.’s common shareholders	370		881		384	2,452
Comprehensive income (loss)	(829)		(7,148)		2,712	(13,104)
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax	8		4		(5)	7
Comprehensive income (loss) attributable to MetLife, Inc.	$ (837)		$ (7,152)		$ 2,717	$ (13,111)
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$ 0.48		$ 1.09		$ 0.50	$ 3.00
Diluted	$ 0.48		$ 1.08		$ 0.50	$ 2.98

MET Balance Sheet

2023-06-30

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $197 and $183, respectively); and amortized cost: $307,045 and $306,025, respectively	$ 283,857	$ 276,780
Equity securities	769	1,684
Contractholder-directed equity securities and fair value option securities, at estimated fair value	10,204	9,668
Mortgage loans (net of allowance for credit loss of $724 and $527, respectively)	92,986	83,763
Policy loans	8,788	8,874
Real estate and real estate joint ventures (includes $310 and $299, respectively, under the fair value option)	13,045	13,137
Other limited partnership interests	14,722	14,414
Short-term investments, principally at estimated fair value	6,921	4,935
Other invested assets (net of allowance for credit loss of $21 and $26, respectively; includes $2,088 and $1,926, respectively, of leveraged and direct financing leases; $338 and $326, respectively, relating to variable interest entities)	19,656	20,038
Total investments	450,948	433,293
Cash and cash equivalents, principally at estimated fair value	15,417	20,195
Accrued investment income	3,505	3,446
Premiums, reinsurance and other receivables	18,530	17,364
Market risk benefits	279	280
Deferred policy acquisition costs and value of business acquired	19,850	19,653
Current income tax recoverable	189	42
Deferred income tax asset	2,377	2,439
Goodwill	9,261	9,297
Other assets	10,977	11,025
Separate account assets	145,946	146,038
Total assets	677,279	663,072
Liabilities
Future policy benefits	190,474	187,222
Policyholder account balances	214,413	210,597
Market risk benefits	3,259	3,763
Other policy-related balances	19,642	18,424
Policyholder dividends payable	366	387
Payables for collateral under securities loaned and other transactions	18,806	20,937
Short-term debt	200	175
Long-term debt	14,539	14,647
Collateral financing arrangement	675	716
Junior subordinated debt securities	3,160	3,158
Deferred income tax liability	752	950
Other liabilities	34,555	25,933
Separate account liabilities	145,946	146,038
Total liabilities	646,787	632,947
Contingencies, Commitments and Guarantees (Note 18)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,191,608,802 and 1,189,831,471 shares issued, respectively; 757,210,115 and 779,098,414 shares outstanding, respectively	12	12
Additional paid-in capital	33,630	33,616
Retained earnings	39,928	40,332
Treasury stock, at cost; 434,398,687 and 410,733,057 shares, respectively	(22,923)	(21,458)
Accumulated other comprehensive income (loss)	(20,386)	(22,621)
Total MetLife, Inc.’s stockholders’ equity	30,261	29,881
Noncontrolling interests	231	244
Total equity	30,492	30,125
Total liabilities and equity	$ 677,279	$ 663,072

Metlife Inc Stock Research

Market Summary

MET Alerts

MET Stock Price

MET RSI Chart

MET Valuation

MET Price/Sales (Trailing)

MET Profitability

MET Fundamentals

MET Revenue

MET Earnings

Price Action

52 Week Range

MET Financial Health

MET Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for MET

Which funds bought or sold MET recently?

Latest Funds Activity

MET Alerts

Schedule 13G FIlings of Metlife

Recent SEC filings of Metlife

Peers (Alternatives to Metlife)

Metlife News

Returns for MET

Cumulative Returns on MET

Risks for MET

What is the probability of a big loss on MET?

How does MET drawdown profile look like?

Financials for Metlife

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)

MET Income Statement

MET Balance Sheet

About Metlife

Market Summary

MET Alerts

MET Stock Price

MET RSI Chart

MET Valuation

MET Price/Sales (Trailing)

MET Profitability

MET Fundamentals

MET Revenue

MET Earnings

Price Action

52 Week Range

MET Financial Health

MET Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for MET

Which funds bought or sold MET recently?

Latest Funds Activity

MET Alerts

Schedule 13G FIlings of Metlife

Recent SEC filings of Metlife

Peers (Alternatives to Metlife)

Metlife News

Returns for MET

Cumulative Returns on MET

Risks for MET

What is the probability of a big loss on MET?

How does MET drawdown profile look like?

Financials for Metlife

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

MET Income Statement

MET Balance Sheet

About Metlife

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)